163 related articles for article (PubMed ID: 35474282)
21. Pathological observations of a long spinal cord lesion in a patient with multiple sclerosis.
Yabata H; Saito Y; Fukuoka T; Akagi A; Riku Y; Sone J; Miyahara H; Doyu M; Yoshida M; Iwasaki Y
Neuropathology; 2022 Jun; 42(3):212-217. PubMed ID: 35170108
[TBL] [Abstract][Full Text] [Related]
22. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
[TBL] [Abstract][Full Text] [Related]
23. [A case of spinal cord infarction accompanied with neuromyelitis optica spectrum pathophysiology].
Katanazaka K; Chihara N; Akazawa S; Ueda T; Sekiguchi K; Matsumoto R
Rinsho Shinkeigaku; 2021 Feb; 61(2):127-131. PubMed ID: 33504754
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
[TBL] [Abstract][Full Text] [Related]
25. Severe Relapse After Cessation of Immunosuppressive Therapy in a Patient With Neuromyelitis Optica Spectrum Disorder.
Hyun JW; Kim G; Kim Y; Jeong IH; Kim SH; Kim HJ
Neurologist; 2016 Nov; 21(6):97-98. PubMed ID: 27801768
[TBL] [Abstract][Full Text] [Related]
26. Anti-MOG and Anti-AQP4 positive neuromyelitis optica spectrum disorder in a patient with myasthenia gravis.
Bates M; Chisholm J; Miller E; Avasarala J; Guduru Z
Mult Scler Relat Disord; 2020 Sep; 44():102205. PubMed ID: 32526697
[TBL] [Abstract][Full Text] [Related]
27. Fingolimod-induced leukoencephalopathy in a patient with neuromyelitis optica spectrum disorder.
Yoshii F; Moriya Y; Ohnuki T; Ryo M; Takahashi W
Mult Scler Relat Disord; 2016 May; 7():53-7. PubMed ID: 27237757
[TBL] [Abstract][Full Text] [Related]
28. AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: A case report and literature review.
Tao S; Zhang Y; Ye H; Guo D
Mult Scler Relat Disord; 2019 Oct; 35():185-192. PubMed ID: 31398657
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors and disease course in aquaporin-4 antibody-positive Chinese patients with acute optic neuritis.
Kang H; Chen T; Li H; Xu Q; Cao S; Wei S
J Neurol; 2017 Oct; 264(10):2130-2140. PubMed ID: 28879451
[TBL] [Abstract][Full Text] [Related]
30. Neuromyelitis optica and aquaporin-4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland.
Siuko M; Tienari PJ; Saastamoinen KP; Atula S; Miettinen A; Kivelä T; Setälä K
Acta Ophthalmol; 2014 Jun; 92(4):387-91. PubMed ID: 23773223
[TBL] [Abstract][Full Text] [Related]
31. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Masaki K; Sato S; Kawano Y; Kira J;
J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):29-34. PubMed ID: 23038741
[TBL] [Abstract][Full Text] [Related]
32. Anti-N-methyl-D-aspartate receptor(NMDAR) antibody encephalitis presents in atypical types and coexists with neuromyelitis optica spectrum disorder or neurosyphilis.
Qin K; Wu W; Huang Y; Xu D; Zhang L; Zheng B; Jiang M; Kou C; Gao J; Li W; Zhang J; Wang S; Luan Y; Yan C; Xu D; Zheng X
BMC Neurol; 2017 Jan; 17(1):1. PubMed ID: 28056870
[TBL] [Abstract][Full Text] [Related]
33. Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.
Akaishi T; Takahashi T; Fujihara K; Misu T; Fujimori J; Takai Y; Nishiyama S; Abe M; Ishii T; Aoki M; Nakashima I
J Neurol; 2021 May; 268(5):1938-1944. PubMed ID: 33416998
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].
Yang Y; Wu WP; Huang DH; Wu L
Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(43):3032-5. PubMed ID: 23328372
[TBL] [Abstract][Full Text] [Related]
35. [Neuromyelitis Optica Spectrum Disorder].
Misu T
Brain Nerve; 2021 May; 73(5):475-482. PubMed ID: 34006678
[TBL] [Abstract][Full Text] [Related]
36. Optic neuritis after ocular trauma in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
Akaishi T; Himori N; Takeshita T; Fujihara K; Misu T; Takahashi T; Fujimori J; Ishii T; Aoki M; Nakazawa T; Nakashima I
Brain Behav; 2021 May; 11(5):e02083. PubMed ID: 33591639
[TBL] [Abstract][Full Text] [Related]
37. Neuromyelitis optica spectrum disorders in South of Tunisia: A rare entity with low seroprevalence of anti-aquaporin 4 autoantibodies.
Mejdoub S; Feki S; Dammak M; Farhat N; Hdiji O; Boukthir S; Hachicha H; Mhiri C; Masmoudi H
Rev Neurol (Paris); 2020 May; 176(4):261-267. PubMed ID: 31668529
[TBL] [Abstract][Full Text] [Related]
38. [A Case of Neuromyelitis Optica Spectrum Disorder Who Relapsed Under Oral Corticosteroid Treatment with Multiple Cerebrospinal Lesions and Severe Neurological Deficits].
Uemoto Y; Shiraishi W; Fujiki R; Furuta K
J UOEH; 2021; 43(2):255-261. PubMed ID: 34092770
[TBL] [Abstract][Full Text] [Related]
39. Clinical features of organizing pneumonia in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.
Furube A; Kadota T; Gochi M; Saito S; Shibata S; Inaki S; Tone K; Takagi M; Matsuno H; Araya J; Yaguchi H; Kuwano K
Respir Investig; 2022 Sep; 60(5):684-693. PubMed ID: 35871065
[TBL] [Abstract][Full Text] [Related]
40. [Neuromyelitis optica].
Ferrán C; Pedemonte V; Turcatti E; González G
Medicina (B Aires); 2019; 79 Suppl 3():60-65. PubMed ID: 31603846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
